New developments in dry powder pulmonary vaccine delivery.
about
Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery SystemsMicro-fractional epidermal powder delivery for improved skin vaccinationNanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells.Preparation and physicochemical characterization of spray-dried and jet-milled microparticles containing bosentan hydrate for dry powder inhalation aerosols.Nanocarriers targeting dendritic cells for pulmonary vaccine delivery.Devices and formulations for pulmonary vaccination.Nasal and pulmonary vaccine delivery using particulate carriers.Devices for dry powder drug delivery to the lung.Particles from preformed polymers as carriers for drug delivery.The long and winding road to inhaled TB therapy: not only the bug's fault.Evaluation of Spray BIO-Max DIM-P in Dogs for Oral Bioavailability and in Nu/nu Mice Bearing Orthotopic/Metastatic Lung Tumor Models for Anticancer Activity.Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation.Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.Non-pathological infection of macaques by an attenuated mycobacterial vaccine is not reactivated in the setting of HIV coinfection.Polyelectrolyte-Enrobed Cancer Cells in View of Personalized Immune-TherapyEngineering of an inhalable DDA/TDB liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying process.Developments in the formulation and delivery of spray dried vaccines.Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?Spray Drying Strategies to Stop Tuberculosis
P2860
Q28076594-33912293-13BE-4A53-A5F3-3CD526069D4AQ34229340-2B0D3B49-1B38-4EB0-A14F-417096DCF551Q36821628-04F62E0E-E239-412F-9D8A-C5A4F1B764DAQ37515669-AB76F3ED-DDF4-4F47-B69C-9180140A32EEQ38051096-506F00FD-CB03-4B39-933B-9E55284FC6B4Q38115814-4A1DF2F3-3A46-448A-9715-3124F57609DBQ38465267-E4C6A179-2504-497B-BA35-EA4FCBB568C7Q38474246-05B30787-FA3E-49ED-AA2F-E978EAA528E0Q38594961-6B9A6832-B500-40BB-B871-97A5BBF17859Q38782463-75042DED-3AF8-4F7C-9B93-FD035C0A22DBQ38921461-B6AC00B9-1302-442E-B5A6-0C0408AC4EA3Q38949613-9955136F-502B-4CE2-BFC6-46CB88806C8EQ39390000-9CDB8E76-0EEF-4E9F-96AA-0416C065CFE8Q41932554-7066742D-AAE2-44C3-9986-0DD0F9A26DD3Q42199258-C6C80365-3E97-4DD3-9480-4F0A7E9825C1Q44461320-3F8D6FD5-0612-43CC-B204-99D3D66F60ACQ47106090-85C913A0-08B5-4ADC-A211-081560D4EB69Q47122978-983E9356-866F-404E-B859-FA2B377A3DEFQ59291746-8C382BDA-B92E-48E2-B7C3-7FA4D1FC6088
P2860
New developments in dry powder pulmonary vaccine delivery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New developments in dry powder pulmonary vaccine delivery.
@en
New developments in dry powder pulmonary vaccine delivery.
@nl
type
label
New developments in dry powder pulmonary vaccine delivery.
@en
New developments in dry powder pulmonary vaccine delivery.
@nl
prefLabel
New developments in dry powder pulmonary vaccine delivery.
@en
New developments in dry powder pulmonary vaccine delivery.
@nl
P2093
P50
P1476
New developments in dry powder pulmonary vaccine delivery
@en
P2093
David A V Morton
Michael de Veer
P304
P356
10.1016/J.TIBTECH.2010.12.009
P577
2011-01-20T00:00:00Z